References
- Bonte J. B., Drochmans A., Ide P. 6Alpha-methyl-17alpha-hydroxyprogesterone acetate as a chemotherapeutic agent in adenocarcinoma of the uterus. Acta Obstet Gynec Scand 1966; 45: 121
- Bonte J., Lassance M., Drochmans A., Ide P. Treatment of adenocarcinomas of the uterus with medroxyprogesterone. Fifth World Congress of Gynaecology and Obstetrics, C. Wood, W. A.W. Walters. Butterworths, Sydney 1967; 680
- Czygan P.-J. Plasma-FSH und -LH während des menstruellen Zyklus, der Menopause und unter Gestagenbehandlung. Acta Endocr (Kbh), Suppl. 1971; 152: 2
- DeMoor P., Steeno O. Comparison of three techniques for the fluorimetric determination of plasma corticosteroids. J Endocr 1963; 28: 59
- Eberlein W. R., Bongiovanni A. M., Francis C. M. A simplified method for the routine measurement of urinary estriol. J Clin Endocr 1958; 18: 1274
- Gross S. J. Histochemistry of normal and abnormal endometrium. Amer J Obstet Gynec 1964; 88: 647
- Hackl H. Hormonbehandeltes Corpuscarcinom und dessen in vitro-Glucosemetabolismus. Arch Gynäk 1968; 206: 252
- Kaiser R. Die Wirkung von Gestagenen beim Korpuscarcinom. Arch Gynäk 1959; 193: 195
- Kompendium i Enzymhistokemi vid fortbildningskurs 24–26 april 1969. Malmö-Lund. 1969
- Levine B. Serum alkaline phosphatase and abnormal uterine bleeding. Obstet Gynec 1964; 24: 274
- Martinez-Gavier J., Dionisi H., Sarria J. A. Progestogens associated with surgery in the treatment of endometrial carcinoma. Fifth World Congress of Gynaecology and Obstetrics, C. Wood, W. A. W. Walters. Butterworths, Sydney 1967; 688
- Mattingly D. A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma. J Clin Path 1962; 15: 374
- McKay D. G., Hertig A. T., Bardawil W. A., Velardo J. T. Histochemical observations on the endometrium. Obstet Gynec 1956; 8: 22
- Norman N., Turter A. R. Cross-reaction with human thyreotropic hormone in a radioimmunoassay for luteinizing hormone. J Oslo City Hosp 1970; 20: 142
- Pearse A. G. E. Histochemistry, 2nd ed. J. & A. Churchill Ltd., London 1960; 832
- Pfleiderer A., Jr. Enzymhistochemische Untersuch-ungen am Carcinom des Corpus uteri. Fortschr Ge-burtsh Gynäk 1968; 36: 1
- Sherman A. I. Progesterone caproate in the treatment of endometrial cancer. Obstet Gynec 1966; 28: 309
- Sherman A. I., Woolf R. B. Endocrine basis for endometrial carcinoma. Amer J Obstet Gynec 1959; 77: 233
- Skulberg A., Endresen G. K. M., Lund I. Halo-thane and liver damage. J Oslo City Hosp 1970; 20: 3
- Thiery M., Willighagen R. G. J. Enzyme histochemistry of adenocarcinoma of the endometrium including hormone-induced changes. Amer J Obstet Gynec 1967; 99: 173
- Varga A., Henriksen E. Clinical and histopathologic evaluation of effect of 17-alpha-hydroxy-progesterone caproate on endometrial cancer. Obstet Gynec 1961; 18: 658
- Varga A., Henriksen E. Histological observations on the effect of 17-alpha-hydroxyprogesterone-17-n-caproate on endometrial carcinoma. Obstet Gynec 1965; 26: 656
- Vokaer R., Loriaux C., Cattoor J.-P. Endometrial carcinoma: alterations in enzymatic activity under the influence of progesterone. Fifth World Congress of Gynaecology and Obstetrics, C. Wood, W. A. W. Walters. Butterworths, Sydney 1967; 648
- Wotiz H. H. Studies in steroid metabolism. XV. The rapid determination of urinary pregnanediol by gas chromatography. Biochim Biophys Acta 1963; 69: 415